A role for peptides in overcoming endosomal entrapment in siRNA delivery - A focus on melittin

Biotechnology Advances

Volumn 33, Issue 6, 2015, Pages 931-940

  Hou, Kirk K ^a   Pan, Hua ^a   Schlesinger, Paul H ^a   Wickline, Samuel A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Endosomal escape; Melittin; siRNA delivery

Indexed keywords

CYTOLOGY; MACHINERY; RNA;

ENDOSOMAL COMPARTMENTS; ENDOSOMAL DISRUPTION; ENDOSOMAL ESCAPES; MELITTIN; PEPTIDE TRANSDUCTION; RESEARCH TOOLS; RNA INTERFERENCE; SIRNA DELIVERY;

PEPTIDES;

AMINO ACID; BIOTECHNOLOGY; CYTOLOGY; CYTOPLASM; MEDICINE; MEMBRANE; MOLECULAR ANALYSIS; PEPTIDE; PROTEIN; RNA;

MELITTIN; SMALL INTERFERING RNA;

ENDOSOME; GENETIC TRANSFECTION; GENETICS; METABOLISM; PROCEDURES; RNA INTERFERENCE;

ENDOSOMES; MELITTEN; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84939258925     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2015.05.005     Document Type: Review

References (108)

1. Åmand H.L., Fant K., Nordén B., Esbjörner E.K. Stimulated endocytosis in penetratin uptake: effect of arginine and lysine. Biochem. Biophys. Res. Commun. 2008, 371:621-625.
2. Andaloussi S.E.L., Lehto T., Mäger I., Rosenthal-Aizman K., Oprea I.I., Simonson O.E., et al. Design of a peptide-based vector, pepfect6, for efficient delivery of siRNA in cell culture and systemically in vivo. Nucleic Acids Res. 2011, 39:3972-3987.
3. arrowheadresearch.com [Internet] Pasadena: Arrowhead Pharmaceuticals; [updated 2012 Oct 29; cited 2015 Mar 12]. Arrowhead presents data showing 99% target knockdown in monkeys without toxicity using subcutaneous formulation of dynamic polyconjugate siRNA delivery system Available from:. http://www.arrowheadresearch.com/press-releases/arrowhead-presents-data-showing-99-target-knockdown-monkeys-without-toxicity-using.
4. arrowheadresearch.com [Internet] Pasadena: Arrowhead Pharmaceuticals; [updated 2014 Nov 10; cited 2015 Mar 12]. "Arrowhead presents data on ARC-520 and ARC-AAT at AASLD the liver meeting 2014" Available from:. http://ir.arrowheadresearch.com/releasedetail.cfm?releaseid=881791.
5. Arthanari Y., Pluen A., Rajendran R., Aojula H., Demonacos C. Delivery of therapeutic shRNA and siRNA by TAT fusion peptide targeting BCR-ABL fusion gene in chronic myeloid leukemia cells. J. Control. Release 2010, 145:272-280.
6. Arukuusk P., Pärnaste L., Oskolkov N., Copolovici D.-M., Margus H., Padari K., et al. New generation of efficient peptide-based vectors, nickfects, for the delivery of nucleic acids. Biochim. Biophys. Acta 2013, 1828:1365-1373.
7. Babiss L. Driving creativity & innovation in research [Internet] [updated 2009 Jan 20; cited 2015 Mar 12]. Available from:. http://www.roche.com/bmk09slides-babiss_v2-e.pdf.
8. Bechinger B., Lohner K. Detergent-like actions of linear amphipathic cationic antimicrobial peptides. BBA - Biomembranes 2006, 1758:1529-1539.
9. Bogaart G.V.D., Guzmán J.V., Mika J.T., Poolman B. On the mechanism of pore formation by melittin. J. Biol. Chem. 2008, 283:33854-33857.
10. Chen C.P., Kim J.S., Steenblock E., Liu D., Rice K.G. Gene transfer with poly-melittin peptides. Bioconjug. Chem. 2006, 17:1057-1062.
11. Chiu Y.L., Ali A., Chu C.Y., Cao H., Rana T.M. Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells. Chem. Biol. 2004, 11:1165-1175.
12. Chou S.T., Leng Q., Scaria P., Woodle M., Mixson A.J. Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo. Cancer Gene Ther. 2011, 18:707-716.
13. Crombez L., Divita G. A non-covalent peptide-based strategy for siRNA delivery. Cell-penetrating Peptides 2011, 349-360. Humana Press, New York. Ü. Langel (Ed.).
14. Crombez L., Aldrian-Herrada G., Konate K., Nguyen Q.N., McMaster G.K., Brasseur R., et al. A new potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. Mol. Ther. 2008, 17:95-103.
15. Crombez L., Morris M.C., Dufort S., Aldrian-Herrada G., Nguyen Q., Mc Master G., et al. Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth. Nucleic Acids Res. 2009, 37:4559-4569.
16. Davidson T.J., Harel S., Arboleda V.A., Prunell G.F., Shelanski M.L., Greene L.A., et al. Highly efficient small interfering RNA delivery to primary mammalian neurons induces microRNA-like effects before mRNA degradation. J. Neurosci. 2004, 24:10040-10046.
17. Deshayes S., Gerbal-Chaloin S., Morris M.C., Aldrian-Herrada G., Charnet P., Divita G., et al. On the mechanism of non-endosomal peptide-mediated cellular delivery of nucleic acids. BBA - Biomembranes 2004, 1667:141-147.
18. Deshayes S., Morris M., Heitz F., Divita G. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy. Adv. Drug Deliv. Rev. 2008, 60:537-547.
19. Deshayes S., Konate K., Rydström A., Crombez L., Godefroy C., Milhiet P.E., et al. Self-assembling peptide-based nanoparticles for siRNA delivery in primary cell lines. Small 2012, 8:2184-2188.
20. Detzer A., Sczakiel G. Phosphorothioate-stimulated uptake of siRNA by mammalian cells: a novel route for delivery. Curr. Top. Med. Chem. 2009, 9:1109-1116.
21. Eccleston A., Eggleston A.K. RNA interference. Nature 2004, 431:337.
22. Eguchi A., Meade B.R., Chang Y.C., Fredrickson C.T., Willert K., Puri N., et al. Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein. Nat. Biotechnol. 2009, 27:567-571.
23. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
24. El-Sayed A., Futaki S., Harashima H. Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. AAPS J. 2009, 11:13-22.
25. Endoh T., Ohtsuki T. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape. Adv. Drug Deliv. Rev. 2009, 61:704-709.
26. Endoh T., Sisido M., Ohtsuki T. Cellular siRNA delivery mediated by a cell-permeant RNA-binding protein and photoinduced RNA interference. Bioconjug. Chem. 2008, 19:1017-1024.
27. Erazo-Oliveras A., Muthukrishnan N., Baker R., Wang T.-Y., Pellois J.-P. Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges. Pharmaceuticals 2012, 5:1177-1209.
28. Erbacher P., Roche A.C., Monsigny M., Midoux P. Putative role of chloroquine in gene transfer into a human hepatoma cell line by DNA/lactosylated polylysine complexes. Exp. Cell Res. 1996, 225:186-194.
29. Ezzat K., Andaloussi S.E.L., Zaghloul E.M., Lehto T., Lindberg S., Moreno P.M.D., et al. Pepfect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation. Nucleic Acids Res. 2011, 39:5284-5298.
30. Ezzat K., Helmfors H., Tudoran O., Juks C., Lindberg S., Padari K., et al. Scavenger receptor-mediated uptake of cell-penetrating peptide nanocomplexes with oligonucleotides. FASEB J. 2012, 26:1172-1180.
31. Ezzat K., Zaghloul E.M., EL Andaloussi S., Lehto T., El-Sayed R., Magdy T., et al. Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions. J. Control. Release 2012, 162:1-8.
32. Frankel A.D., Pabo C.O. Cellular uptake of the TAT protein from human immunodeficiency virus. Cell 1988, 55:1189-1193.
33. Futaki S., Ohashi W., Suzuki T., Niwa M., Tanaka S., Ueda K., et al. Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug. Chem. 2001, 12:1005-1011.
34. Geoghegan J.C., Gilmore B.L., Davidson B.L. Gene silencing mediated by siRNA-binding fusion proteins is attenuated by double-stranded RNA-binding domain structure. Mol. Ther. Nucleic Acids 2012, 1:e53.
35. Gilleron J., Querbes W., Zeigerer A., Borodovsky A., Marsico G., Schubert U., et al. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat. Biotechnol. 2013, 31:638-646.
36. Hassane F.S., Saleh A.F., Abes R., Gait M.J., Lebleu B. Cell penetrating peptides: overview and applications to the delivery of oligonucleotides. Cell. Mol. Life Sci. 2010, 67:715-726.
37. Hassane F.S., Abes R., El Andaloussi S., Lehto T., Sillard R., Langel U., et al. Insights into the cellular trafficking of splice redirecting oligonucleotides complexed with chemically modified cell-penetrating peptides. J. Control. Release 2011, 153:163-172.
38. Haussecker D. The business of RNAi therapeutics in 2012. Mol. Ther. Nucleic Acids 2012, 1:e8.
39. Heitz F., Morris M.C., Divita G. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br. J. Pharmacol. 2009, 157:195-206.
40. Hou K.K., Pan H., Lanza G.M., Wickline S.A. Melittin derived peptides for nanoparticle based siRNA transfection. Biomaterials 2013, 34:3110-3119.
41. Hou K.K., Pan H., Ratner L., Schlesinger P.H., Wickline S.A. Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides. ACS Nano 2013, 7:8605-8615.
42. Hoyer J., Neundorf I. Knockdown of a G protein-coupled receptor through efficient peptide-mediated siRNA delivery. J. Control. Release 2012, 161:826-834.
43. Hoyer J., Neundorf I. Peptide vectors for the nonviral delivery of nucleic acids. Acc. Chem. Res. 2012, 45:1048-1056.
44. idtdna.com [Internet]. Coralville: Integrated DNA Technologies; [updated 2009 Jul 29; cited 2015 Mar 12]. IDT introduces novel peptide delivery system for dsRNA. Available from:. http://www.idtdna.com/pages/docs/press-releases/2009-transductin.pdf?sfvrsn=6.
45. Ifediba M.A., Medarova Z., Ng S.W., Yang J., Moore A. siRNA delivery to CNS cells using a membrane translocation peptide. Bioconjug. Chem. 2010, 21:803-806.
46. Kim W.J., Christensen L.V., Jo S., Yockman J.W., Jeong J.H., Kim Y.-H., et al. Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma. Mol. Ther. 2006, 14:343-350.
47. Kim J., Lee S.H., Choe J., Park T.G. Intracellular small interfering RNA delivery using genetically engineered double-stranded RNA binding protein domain. J. Gene Med. 2009, 11:804-812.
48. Kim S.W., Kim N.Y., Choi Y.B., Park S.H., Yang J.M., Shin S. RNA interference in vitro and in vivo using an arginine peptide/siRNA complex system. J. Control. Release 2010, 143:335-343.
49. Kumar P., Wu H., McBride J.L., Jung K.-E., Hee Kim M., Davidson B.L., et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007, 448:39-43.
50. Ladokhin A.S., White S.H. 'Detergent-like' permeabilization of anionic lipid vesicles by melittin. BBA - Biomembranes 2001, 1514:253-260.
51. Langlet-Bertin B., Leborgne C., Scherman D., Bechinger B., Mason A.J., Kichler A. Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery. Pharm. Res. 2010, 27:1426-1436.
52. Lee M.-T., Hung W.-C., Chen F.-Y., Huang H.W. Mechanism and kinetics of pore formation in membranes by water-soluble amphipathic peptides. PNAS 2008, 105:5087-5092.
53. Lehto T., Abes R., Oskolkov N., Suhorutšenko J., Copolovici D.-M., Mäger I., et al. Delivery of nucleic acids with a stearylated (RXR)4 peptide using a non-covalent co-incubation strategy. J. Control. Release 2010, 141:42-51.
54. Lehto T., Simonson O.E., Mäger I., Ezzat K., Sork H., Copolovici D.-M., et al. A peptide-based vector for efficient gene transfer in vitro and in vivo. Mol. Ther. 2011, 19:1457-1467.
55. Lindberg S., Muñoz-Alarcón A., Helmfors H., Mosqueira D., Gyllborg D., Tudoran O., et al. Pepfect15, a novel endosomolytic cell-penetrating peptide for oligonucleotide delivery via scavenger receptors. Int. J. Pharm. 2013, 441:242-247.
56. Lo S.L., Wang S. An endosomolytic tat peptide produced by incorporation of histidine and cysteine residues as a nonviral vector for DNA transfection. Biomaterials 2008, 29:2408-2414.
57. Lundberg P., El-Andaloussi S., Sütlü T., Johansson H., Langel Ü. Delivery of short interfering RNA using endosomolytic cell-penetrating peptides. FASEB J. 2007, 21:2664-2671.
58. Lundin P., Johansson H., Guterstam P., Holm T., Hansen M., Langel Ü., et al. Distinct uptake routes of cell-penetrating peptide conjugates. Bioconjug. Chem. 2008, 19:2535-2542.
59. Mäe M., Andaloussi S.E., Lehto T., Langel Ü. Chemically modified cell-penetrating peptides for the delivery of nucleic acids. Expert Opin. Drug Deliv. 2009, 6:1195-1205.
60. Mäe M., EL Andaloussi S., Lundin P., Oskolkov N., Johansson H.J., Guterstam P., et al. A stearylated cpp for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy. J. Control. Release 2009, 134:221-227.
61. McCaffrey A.P., Meuse L., Pham T.-T.T., Conklin D.S., Hannon G.J., Kay M.A. Gene expression: RNA interference in adult mice. Nature 2002, 418:38-39.
62. Meade B.R., Dowdy S.F. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. Adv. Drug Deliv. Rev. 2007, 59:134-140.
63. Meade B.R., Dowdy S.F. Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Adv. Drug Deliv. Rev. 2008, 60:530-536.
64. Meyer M., Zintchenko A., Ogris M., Wagner E. A dimethylmaleic acid-melittin-polylysine conjugate with reduced toxicity, pH-triggered endosomolytic activity and enhanced gene transfer potential. J. Gene Med. 2007, 9:797-805.
65. Meyer M., Philipp A., Oskuee R., Schmidt C., Wagner E. Breathing life into polycations: functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery. J. Am. Chem. Soc. 2008, 130:3272-3273.
66. Meyer M., Dohmen C., Philipp A., Kiener D., Maiwald G., Scheu C., et al. Synthesis and biological evaluation of a bioresponsive and endosomolytic siRNA-polymer conjugate. Mol. Pharm. 2009, 6:752-762.
67. Moschos S.A., Jones S.W., Perry M.M., Williams A.E., Erjefalt J.S., Turner J.J., et al. Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjug. Chem. 2007, 18:1450-1459.
68. Muratovska A., Eccles M.R. Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett. 2004, 558:63-68.
69. Nakase I., Akita H., Kogure K., Gräslund A., Langel Ü., Harashima H., et al. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides. Acc. Chem. Res. 2012, 45:1132-1139.
70. Neundorf I., Rennert R., Hoyer J., Schramm F., Löbner K., Kitanovic I., et al. Fusion of a short HA2-derived peptide sequence to cell-penetrating peptides improves cytosolic uptake, but enhances cytotoxic activity. Pharmaceuticals 2009, 2:49-65.
71. Ohkuma S., Poole B. Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. J. Cell Biol. 1981, 90:656-664.
72. Okuda T., Kawaguchi Y., Okamoto H. Enhanced gene delivery and/or efficacy by functional peptide and protein. Curr. Top. Med. Chem. 2009, 9:1098-1108.
73. Oršolić N. Bee venom in cancer therapy. Cancer Metastasis Rev. 2012, 31:173-194.
74. Overhoff M., Sczakiel G. Phosphorothioate-stimulated uptake of short interfering RNA by human cells. EMBO Rep. 2005, 6:1176-1181.
75. Pan H., Myerson J.W., Ivashyna O., Soman N.R., Marsh J.N., Hood J.L., et al. Lipid membrane editing with peptide cargo linkers in cells and synthetic nanostructures. FASEB J. 2010, 24:2928-2937.
76. Parmar R.G., Busuek M., Walsh E.S., Leander K.R., Howell B.J., Sepp-Lorenzino L., et al. Endosomolytic bioreducible poly(amido amine disulfide) polymer conjugates for the in vivo systemic delivery of siRNA therapeutics. Bioconjug. Chem. 2013, 24:640-647.
77. Pratt J.P., Ravnic D.J., Huss H.T., Jiang X., Orozco B.S., Mentzer S.J. Melittin-induced membrane permeability: a nonosmotic mechanism of cell death. In Vitro Cell. Dev. Biol. Anim. 2005, 41:349-355.
78. Qi W., Ding D., Zhu H., Lu D., Wang Y., Ding J., et al. Efficient siRNA transfection to the inner ear through the intact round window by a novel proteidic delivery technology in the chinchilla. Gene Ther. 2014, 21:10-18.
79. Räägel H., Hein M., Kriiska A., Säälik P., Florén A., Langel Ü., et al. Cell-penetrating peptide secures an efficient endosomal escape of an intact cargo upon a brief photo-induction. Cell. Mol. Life Sci. 2013, 70:4825-4839.
80. Raghuraman H., Chattopadhyay A. Melittin: a membrane-active peptide with diverse functions. Biosci. Rep. 2007, 27:189-223.
81. Regberg J., Srimanee A., Erlandsson M., Sillard R., Dobchev D.A., Karelson M., et al. Rational design of a series of novel amphipathic cell-penetrating peptides. Int. J. Pharm. 2014, 464:111-116.
82. Ren Y., Cheung H.W., Maltzhan Gv, Agrawal A., Cowley G.S., Weir B.A., et al. Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4. Sci. Transl. Med. 2012, 4:147ra112.
83. Rozema D.B., Ekena K., Lewis D.L., Loomis A.G., Wolff J.A. Endosomolysis by masking of a membrane-active agent (EMMA) for cytoplasmic release of macromolecules. Bioconjug. Chem. 2003, 14:51-57.
84. Rozema D.B., Lewis D.L., Wakefield D.H., Wong S.C., Klein J.J., Roesch P.L., et al. Dynamic polyconjugates for targeted in vivo delivery of siRNA to hepatocytes. PNAS 2007, 104:12982-12987.
85. Rydström A., Deshayes S., Konate K., Crombez L., Padari K., Boukhaddaoui H., et al. Direct translocation as major cellular uptake for CADY self-assembling peptide-based nanoparticles. PLoS One 2011, 6:e25924.
86. Sakurai K., Amarzguioui M., Kim D.H., Alluin J., Heale B., Song M.S., et al. A role for human dicer in pre-RISC loading of siRNAs. Nucleic Acids Res. 2011, 39:1510-1525.
87. Sessa G., Freer J.H., Colacicco G., Weissmann G. Interaction of a lytic polypeptide, melittin, with lipid membrane systems. J. Biol. Chem. 1969, 244:3575-3582.
88. Shai Y. Mode of action of membrane active antimicrobial peptides. Biopolymers 2002, 66:236-248.
89. Shiraishi T., Nielsen P.E. Enhanced delivery of cell-penetrating peptide-peptide nucleic acid conjugates by endosomal disruption. Nat. Protoc. 2006, 1:633-636.
90. sigmaaldrich.com [Internet] St. Louis: Sigma Aldrich; [cited 2015 Mar 12]. N-TER nanoparticle siRNA transfection system siRNA delivery to hard-to-transfect cell types. Available from:. http://www.sigmaaldrich.com/life-science/functional-genomics-and-rnai/sirna/nter.html.
91. Simeoni F., Morris M.C., Heitz F., Divita G. Insight into the mechanism of the peptide-based gene delivery system MPG: implications for delivery of siRNA into mammalian cells. Nucleic Acids Res. 2003, 31:2717-2724.
92. Soman N.R., Baldwin S.L., Hu G., Marsh J.N., Lanza G.M., Heuser J.E., et al. Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth. J. Clin. Invest. 2009, 119:2830-2842.
93. Suhorutsenko J., Oskolkov N., Arukuusk P., Kurrikoff K., Eriste E., Copolovici D.-M., et al. Cell-penetrating peptides, pepfects, show no evidence of toxicity and immunogenicity in vitro and in vivo. Bioconjug. Chem. 2011, 22:2255-2262.
94. Tan Y.-X., Chen C., Wang Y.-L., Lin S., Wang Y., Li S.-B., et al. Truncated peptides from melittin and its analog with high lytic activity at endosomal pH enhance branched polyethylenimine-mediated gene transfection. J. Gene Med. 2012, 14:241-250.
95. Tanaka K., Kanazawa T., Ogawa T., Takashima Y., Fukuda T., Okada H. Disulfide crosslinked stearoyl carrier peptides containing arginine and histidine enhance siRNA uptake and gene silencing. Int. J. Pharm. 2010, 398:219-224.
96. Trabulo S., Cardoso A.L., Mano M., de Lima M.C.P. Cell-penetrating peptides - mechanisms of cellular uptake and generation of delivery systems. Pharmaceuticals 2010, 3:961-993.
97. Turner J.J., Arzumanov A.A., Gait M.J. Synthesis, cellular uptake and HIV-1 TAT-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides. Nucleic Acids Res. 2005, 33:27-42.
98. Turner J.J., Williams D., Owen D., Gait M.J. Disulfide conjugation of peptides to oligonucleotides and their analogs. Current Protocols in Nucleic Acid Chemistry 2006, John Wiley & Sons, Inc., Hoboken, (unit 4.28). S.L. Beaucage, D.E. Bergstrom, P. Herdewijin, A. Matsuda (Eds.).
99. Turner J.J., Jones S., Fabani M.M., Ivanova G., Arzumanov A.A., Gait M.J. RNA targeting with peptide conjugates of oligonucleotides, siRNA and PNA. Blood Cells Mol. Dis. 2007, 38:1-7.
100. Varkouhi A.K., Scholte M., Storm G., Haisma H.J. Endosomal escape pathways for delivery of biologicals. J. Control. Release 2011, 151:220-228.
101. Veldhoen S., Laufer S.D., Trampe A., Restle T. Cellular delivery of small interfering RNA by a non-covalently attached cell-penetrating peptide: quantitative analysis of uptake and biological effect. Nucleic Acids Res. 2006, 34:6561-6573.
102. Veldhoen S., Laufer S.D., Restle T. Recent developments in peptide-based nucleic acid delivery. Int. J. Mol. Sci. 2008, 9:1276-1320.
103. Wadia J.S., Stan R.V., Dowdy S.F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 2004, 10:310-315.
104. Wang M., Thanou M. Targeting nanoparticles to cancer. Pharmacol. Res. 2010, 62:90-99.
105. Wibo M., Poole B. Protein degradation in cultured cells II. The uptake of chloroquine by rat fibroblasts and the inhibition of cellular protein degradation and cathepsin B1. J. Cell Biol. 1974, 63:430-440.
106. Wooddell C.I., Rozema D.B., Hossbach M., John M., Hamilton H.L., Chu Q., et al. Hepatocyte-targeted RNAi therapeutics for the treatment of chronic hepatitis B virus infection. Mol. Ther. 2013, 21:973-985.
107. Yu W., Pirollo K.F., Yu B., Rait A., Xiang L., Huang W., et al. Enhanced transfection efficiency of a systemically delivered tumor-targeting immunolipoplex by inclusion of a pH-sensitive histidylated oligolysine peptide. Nucleic Acids Res. 2004, 32:e48.
108. Zhou H.-f., Yan H., Pan H., Hou K.K., Akk A., Springer L.E., et al. Peptide-siRNA nanocomplexes targeting NF-κB subunit p65 suppress nascent experimental arthritis. J. Clin. Invest. 2014, 124:4363-4374.